Cabot Corp (CBT) Stock Analysis

Verdict: WATCH (do not buy)

Strong operational beats are being overshadowed by a high-stakes CEO transition and growth-deceleration downgrades at the cycle peak.

Investment score: 58/100

Analysis as of

Is Cabot Corp stock worth reviewing? AI model thesis

Hold. CBT is fundamentally sound with superior margins (15.7% OpM) vs peers like Dow (-0.1%), but leadership changes and cyclical revenue declines (-8.5%) limit near-term upside.

7-factor investment score

Cabot Corp opportunities and risks

What speaks for CBT

What speaks against CBT

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
CBT22.2x1.1x6.3x22.9%5.2%6.8%
DOWn/a0.5x16.7x9.8%-2.9%2.0%
WLKn/a0.9xn/a5.0%-10.9%-2.7%
HWKN34.4x2.5x17.4x22.3%7.3%3.3%
OLNn/a0.3x11.0x6.9%-2.1%0.4%
PCTn/a131.7xn/a-1293.3%-2062.4%-12.2%
Peer mediann/a0.9x11.0x6.9%-2.9%0.4%

Frequently asked questions about Cabot Corp (CBT)

Is CBT stock a good investment?

The cached TradeMates AI model rates Cabot Corp as WATCH (do not buy) with an investment score of 58/100. Hold. CBT is fundamentally sound with superior margins (15.7% OpM) vs peers like Dow (-0.1%), but leadership changes and cyclical revenue declines (-8.5%) limit near-term upside. This is algorithmic model output, not personal investment advice.

Is CBT stock a buy?

The TradeMates model verdict for CBT is WATCH (do not buy) with an investment score of 58/100. Treat this as a model signal to review, not a personal buy recommendation.